Search Within

Nursing

Formats
  1. Journal Article (1747)
  2. Meeting Abstract (1582)
  3. Book Section (130)
  4. Review (109)
  5. Editorial (92)
  6. Conference Paper (27)
  7. Research Letter (17)
  8. Book Whole (15)
  9. Miscellaneous (15)
  10. Correspondence (12)
  11. Guidelines (10)
Groups
  1. Department of Medicine (1497)
  2. Advanced Practice Providers (1172)
  3. Survivorship Research (962)
  4. Solid Tumor Oncology Division (884)
  5. Epidemiology and Biostatistics (641)
  6. Hematologic Malignancies, Division of (611)

More Groups

People
  1. William Rosa (235)
  2. Nessa Coyle (123)
  3. Sergio Giralt (117)
  4. Mark Kris (114)
  5. Howard Scher (100)
  6. Andrew Zelenetz (99)

More People

Years
  1. 2026 (7)
  2. 2025 (184)
  3. 2024 (213)
  4. 2023 (195)
  5. 2022 (202)
  6. 2021 (171)

More Years

Publications
  1. Journal of Clinical Oncology (451)
  2. Oncology Nursing Forum (420)
  3. Blood (212)
  4. Clinical Journal of Oncology Nursing (121)
  5. Biology of Blood and Marrow Transplantation (88)
  6. Clinical Cancer Research (71)

More Publications

Publishers
  1. Oncology Nursing Society (ONS) (566)
  2. American Society of Clinical Oncology (492)
  3. Elsevier Inc. (428)
  4. Lippincott Williams & Wilkins (260)
  5. American Society of Hematology (226)
  6. American Association for Cancer Research (158)

More Publishers

Results (3756)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission
    Journal Article

    Diefenbach, C. S. M.; Gnjatic, S.; Sabbatini, P.; Aghajanian, C.; Hensley, M. L.; Spriggs, D. R.; Iasonos, A.; Lee, H.; Dupont, B.; Pezzulli, S.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Randomized controlled trial of a special acupuncture technique for pain after thoracotomy
    Journal Article

    Deng, G.; Rusch, V.; Vickers, A.; Malhotra, V.; Ginex, P.; Downey, R.; Bains, M.; Park, B.; Rizk, N.; Flores, R.; more...
    Journal of Thoracic and Cardiovascular Surgery (2008)

    Fulltext@MSK | Save
  • A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: A retrospective experience
    Journal Article

    Dash, A.; Pettus, J. A. 4th; Herr, H. W.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Russo, P.; Boyle, M. G.; Milowsky, M. I.; Bajorin, D. F.
    Cancer (2008)

    Fulltext@MSK | Save
  • Palliative care is an integral part of comprehensive cancer care
    Journal Article

    Coyle, N.
    Oncology Nursing Forum (2008)

    Fulltext@MSK | Save
  • Pharmacogenomic analysis of a randomized phase II trial (BOND 2) of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer
    Meeting Abstract

    Zhang, W.; Yang, D.; Capanu, M.; Hollywood, E.; Lue-Yat, M.; Borucka, E.; Azuma, M.; Gordon, M.; Saltz, L.; Lenz, H.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of a novel capecitabine schedule based on Norton-Simon mathematical modeling
    Meeting Abstract

    Theodoulou, M.; Traina, T. A.; Dugan, U.; Lake, D.; Fornier, M.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Volumetric 3D CT analysis - an early predictor of response to therapy
    Meeting Abstract

    Schwartz, L. H.; Curran, S.; Trocola, R.; Randazzo, J.; Ilson, D.; Kelsen, D.; Shah, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase II study of preoperative chemotherapy with irinotecan (CPT) and cisplatin (CIS) for gastric cancer (NCI 5917): FDG-PET/CT predicts patient outcome
    Meeting Abstract

    Shah, M. A.; Yeung, H.; Coit, D.; Trocola, R.; Ilson, D.; Randazzo, J.; Tang, L.; Brennan, M.; Divgi, C.; Kelsen, D. P.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Effect of percutaneous biliary drainage (PBD) for malignant biliary obstruction (MBO) on quality of life (QoL)
    Meeting Abstract

    Robson, P. M.; Heffernan, N.; Holmes, R.; Gonen, M.; Schubert, J.; Getrajdman, G. I.; Brody, L. A.; Brown, K. T.; Covey, A. M.; Blumgart, L. H.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Bevacizumab 5mg/kg can be safely infused over 10 minutes
    Meeting Abstract

    Reidy, D. L.; Chung, K. Y.; Timoney, J. P.; Park, V.; Hollywood, E.; Sklarin, N.; Muller, R.; Saltz, L.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save